ArticleImmunity, inflammation and disease2026
Clinical Value the Neutrophil CD64 Index in Predicting the Severity of Hemorrhagic Fever With Renal Syndrome.
Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Value the Neutrophil CD64 Index in Predicting the Severity of Hemorrhagic Fever With Renal Syndrome.Immunity, inflammation and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectiveThe hemorrhagic fever with renal syndrome (HFRS) is an acute viral infectious disease characterized by multi-system damage involving complex mechanisms. Effective identification of critically ill patients is essential for the prognosis of HFRS. The aim of this study was to investigate the utility of the neutrophil CD64 index (nCD64 index) in predicting the severity of HFRS.
methodsThis study included 64 HFRS patients from the Center for Infectious Diseases of the Second Affiliated Hospital of Air Force Medical University between October 2023 and March 2024. The expression of CD64 on neutrophils was assessed using flow cytometry, and the nCD64 index was calculated. White blood cell (WBC), Procalcitonin (PCT), C-reactive protein (CRP), Il-6, and creatinine levels were measured for each patient, and Sequential Organ Failure Assessment (SOFA) scores were determined.
resultsThe expression of nCD64 was generally elevated in HFRS patients and demonstrated a positive correlation with WBC, neutrophil, lymphocyte, monocyte, and PCT, as well as a negative correlation with platelet. The receiver operating characteristic (ROC) curve of nCD64 index for predicting high SOFA score patients outperformed those of CRP, creatinine and WBC, and was equivalent to that of IL-6 and PCT.
conclusionThe nCD64 index has the potential to serve as an effective biomarker for monitoring disease progression and assessing treatment efficacy in HFRS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.